Aerospace Changfeng announced that the net loss attributable to the owner of the parent company for the first half year of 2026 is estimated to be between 58 million yuan and 62 million yuan, and the net loss for the same period last year is 555.91 million yuan. The net loss attributable to the owner of the parent company for the first half year of 2026 is estimated to be 67.02 million yuan to 71.02 million yuan, and the net loss after deducting non-recurring profit and loss for the same period of the previous year is 61.157 million yuan. The main reason for this period's performance forecast loss: First, the military electronics industry's power supply business was affected by delays in product delivery in the first half of the year, and product settlement experienced a short-term decline compared to the same period last year. Furthermore, the infrared optoelectronics business did not substantially improve profitability due to a slowdown in end user demand. At the same time, accounts receivable repayment was insufficient in the first half of the year, leading to a year-on-year increase in accounts receivable calculation and impairment preparations. Second, market development fell short of expectations due to reasons such as delays in ECMO product registration and forensics in the high-end medical equipment industry.

Aerospace Changfeng announced that the net loss attributable to the owner of the parent company for the first half year of 2026 is estimated to be between 58 million yuan and 62 million yuan, and the net loss for the same period last year is 555.91 million yuan. The net loss attributable to the owner of the parent company for the first half year of 2026 is estimated to be 67.02 million yuan to 71.02 million yuan, and the net loss after deducting non-recurring profit and loss for the same period of the previous year is 61.157 million yuan. The main reason for this period's performance forecast loss: First, the military electronics industry's power supply business was affected by delays in product delivery in the first half of the year, and product settlement experienced a short-term decline compared to the same period last year. Furthermore, the infrared optoelectronics business did not substantially improve profitability due to a slowdown in end user demand. At the same time, accounts receivable repayment was insufficient in the first half of the year, leading to a year-on-year increase in accounts receivable calculation and impairment preparations. Second, market development fell short of expectations due to reasons such as delays in ECMO product registration and forensics in the high-end medical equipment industry.